Enabled Therapeutics strengthens leadership team as it redefines neurology with on-site drug synthesis and precision brain therapeutics.

Enabled Therapeutics strengthens leadership team as it redefines neurology with on-site drug synthesis and precision brain therapeutics.
Jivan Achreja is Co-Founder and CTO of Recombo.AI and ETHOS Scientific, and a veteran technology leader in healthcare and life sciences. He previously held executive roles at Advarra, Medidata Solutions, and YPrime, with expertise in platform innovation, clinical research, and strategic growth. He holds a BS in Biology, Chemistry, and Entrepreneurship from the University of […]
Enabled Therapeutics Gains FDA Alignment for CPT-021: A First-of-Its-Kind Targeted Therapy for Alzheimer’s